Ara
Toplam kayıt 17, listelenen: 11-17
Guideline-adherent therapy for stroke prevention in atrial fibrillation in different health care settings: Results from ramses study
(Elsevier B.V., 2017)
Objective No studies have been conducted in Turkey to compare the quality of stroke prevention therapies provided in different healthcare settings in patients with atrial fibrillation (AF). Therefore, we aimed to evaluate ...
The relationship between the S-wave in lead 1 and recurrence of RVOT PVC ablation
(Churchill Livingstone Inc Medical Publishers, 2018)
Background: Radiofrequency catheter ablation (CA) is a common non-pharmacological treatment option for ventricular premature contractions (PVCs) originating from right ventricular outflow tract (RVOT). In this study, we ...
Hemopericardium and cardiac tamponade in a patient treated with dabigatran etexilate
(Korean Soc Cardiology, 2016)
Dabigatran etexilate is one of the new oral anticoagulants approved to reduce the risk of stroke in patients with atrial fibrillation (AF). A variety of bleeding complications with dabigatran have been reported, but reports ...
Adjusting the QRS duration by body mass index for prediction of response to cardiac resynchronization therapy: Does one QRS size fit all?
(Wiley, 2016)
Background: QRS duration (QRSd) is known to be affected by body weight and length. We tested the hypothesis that adjusting the QRSd by body mass index (BMI) may provide individualization for patient selection and improve ...
Effect of cardiac resynchronization therapy on mitral valve geometry: A novel aspect as "reversed mitral remodeling"
(Springer, 2018)
Amelioration of the valvular geometry is a possible mechanism for mitral regurgitation (MR) improvement in patients receiving cardiac resynchronization therapy (CRT). We aimed to establish the precise definition, incidence, ...
How accurate are manufacturers' recommendations in determining ineligibility for transfemoral transcatheter aortic valve implantation?
(Sociedade Portuguesa De Cardiologia, 2023)
Introduction: Up to one-third of patients indicated for transcatheter aortic valve implantation (TAVI) may be unsuitable for transfemoral TAVI (TF-TAVI) according to manufacturers' recommendations and numerous professional ...
Long-term outcomes of patients presenting with acute coronary syndrome and implanted with bioresorbable scaffold
(Yuzuncu Yıl University Faculty of Medicine, 2022)
A bioresorbable scaffold (BRS) has been used in the latest stages of stent technology and is a less-known material than drug-eluting stents (DES). In this study, we aimed to evaluate the long-term clinical outcomes of BRS ...